Lentiviral Vpx Accessory Factor Targets VprBP/DCAF1 Substrate Adaptor for Cullin 4 E3 Ubiquitin Ligase to Enable Macrophage Infection
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Vpx is a small virion-associated adaptor protein encoded by viruses of the HIV-2/SIVsm lineage of primate lentiviruses that enables these viruses to transduce monocyte-derived cells. This probably reflects the ability of Vpx to overcome an as yet uncharacterized block to an early event in the virus life cycle in these cells, but the underlying mechanism has remained elusive. Using biochemical and proteomic approaches, we have found that Vpx protein of the pathogenic SIVmac 239 strain associates with a ternary protein complex comprising DDB1 and VprBP subunits of Cullin 4-based E3 ubiquitin ligase, and DDA1, which has been implicated in the regulation of E3 catalytic activity, and that Vpx participates in the Cullin 4 E3 complex comprising VprBP. We further demonstrate that the ability of SIVmac as well as HIV-2 Vpx to interact with VprBP and its associated Cullin 4 complex is required for efficient reverse transcription of SIVmac RNA genome in primary macrophages. Strikingly, macrophages in which VprBP levels are depleted by RNA interference resist SIVmac infection. Thus, our observations reveal that Vpx interacts with both catalytic and regulatory components of the ubiquitin proteasome system and demonstrate that these interactions are critical for Vpx ability to enable efficient SIVmac replication in primary macrophages. Furthermore, they identify VprBP/DCAF1 substrate receptor for Cullin 4 E3 ubiquitin ligase and its associated protein complex as immediate downstream effector of Vpx for this function. Together, our findings suggest a model in which Vpx usurps VprBP-associated Cullin 4 ubiquitin ligase to enable efficient reverse transcription and thereby overcome a block to lentivirus replication in monocyte-derived cells, and thus provide novel insights into the underlying molecular mechanism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It was previously reported that in myeloid cells transduced with HIV-2, Vpx prevents the inhibition of HIV-1 infection by associating with and hijacking a cellular E3 ubiquitin-protein ligase complex, including the proteins cullin 4 and DCAF1 [82,83].”
From Proteomic approaches to uncovering virus–host protein interactions during the progression of viral infection (2016) · cites this paper as [82]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells
Elbashir, S. M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., & Tuschl, T. (2001) · Nature · doi:10.1038/35078107 · Cited by 9,456 · cited 1×
“To obtain further insight into the role of VprBP, we knocked down its expression in macrophages by RNA interference (RNAi, [25]).”
BackgroundEng, J. K., McCormack, A. L., & Yates, J. R. (1994) · Journal of the American Society for Mass Spectrometry · doi:10.1016/1044-0305(94)80016-2 · Cited by 6,484 · cited 1×
“Tandem mass (MS/MS) spectra were interpreted using SEQUEST [37] against a database of 82242 sequences, consisting of hfa-tagged SIVmac Vpx, usual contaminants, and 40873 human proteins, as well as, to estimate false discovery rates, randomized amino acid sequences derived from each non-redundant protein entry.”
MethodFunction and regulation of cullin–RING ubiquitin ligases
Petroski, M. D., & Deshaies, R. J. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1547 · Cited by 2,148 · cited 2×
“substrate adaptor for Cullin 4-based E3 ubiquitin ligases ([15] reviewed in [16,17]).”
BackgroundTabb, D. L., McDonald, W. H., & Yates, J. R. (2002) · Journal of Proteome Research · doi:10.1021/pr015504q · Cited by 1,367 · cited 1×
“Peptide hits from multiple runs were compared using CONTRAST [38].”
MethodGroisman, R., Polanowska, J., Kuraoka, I., Sawada, J.-I., Saijo, M., Drapkin, R., Kisselev, A. F., Tanaka, K., & Nakatani, Y. (2003) · Cell · doi:10.1016/s0092-8674(03)00316-7 · Cited by 744 · cited 1×
“[23]).”
Stremlau, M., Perron, M., Lee, M., Li, Y., Song, B., Javanbakht, H., Diaz-Griffero, F., Anderson, D. J., Sundquist, W. I., & Sodroski, J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509996103 · Cited by 739 · cited 1×
“The phenotype of Vpx-deficient virions is reminiscent of that resulting from a block to retrovirus replication imposed by tripartite motif protein 5α (TRIM5α) restriction factors. TRIM5α is a E3 ubiquitin ligase that inactivates the incoming virions, probably by deregulating their uncoating so rapidly that the late re…”
BackgroundJin, J., Arias, E. E., Chen, J., Harper, J. W., & Walter, J. C. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.08.010 · Cited by 632 · cited 1×
“). Cullin 4 is a scaffold protein that assembles a family of E3 ubiquitin ligase complexes. DDB1 is an obligatory subunit of all Cullin 4 E3's that bridges the catalytic cores organized on the Cullin 4 scaffold to a substrate-recruiting subunit, and VprBP/DCAF1 is a putative substrate adaptor for Cullin 4-based E3 ubi…”
BackgroundDCAFs, the Missing Link of the CUL4-DDB1 Ubiquitin Ligase
Lee, J., & Zhou, P. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.06.001 · Cited by 460 · cited 1×
“substrate adaptor for Cullin 4-based E3 ubiquitin ligases ([15] reviewed in [16,17]).”
BackgroundPaxton, W., Connor, R. I., & Landau, N. R. (1993) · Journal of Virology · doi:10.1128/jvi.67.12.7229-7237.1993 · Cited by 371 · cited 1×
“Furthermore, the incoming virions probably contain at most only several hundred Vpx molecules, similar to Vpr, which also is virion recruited through its interaction with Gag p6 [6,30,31].”
BackgroundLe Rouzic, E., Belaïdouni, N., Estrabaud, E., Morel, M., Rain, J.-C., Transy, C., & Margottin-Goguet, F. (2007) · Cell Cycle · doi:10.4161/cc.6.2.3732 · Cited by 267
Wu, X., Anderson, J. L., Campbell, E. M., Joseph, A. M., & Hope, T. J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510483103 · Cited by 266 · cited 1×
“TRIM5a is a E3 ubiquitin ligase that inactivates the incoming virions, probably by deregulating their uncoating so rapidly that the late reverse transcripts fail to accumulate [26,27,28].”
BackgroundConstruction and In Vitro Properties of SIV mac Mutants with Deletions in "Nonessential" Genes
GIBBS, J. S., REGIER, D. A., & DESROSIERS, R. C. (1994) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1994.10.333 · Cited by 256 · cited 3×
“has no overt effect in primary T lymphocytes, as well as T and monocytic cell lines [1,2,3].”
Progression to AIDS in the absence of a gene for vpr or vpx
Gibbs, J. S., Lackner, A. A., Lang, S. M., Simon, M. A., Sehgal, P. K., Daniel, M. D., & Desrosiers, R. C. (1995) · Journal of Virology · doi:10.1128/jvi.69.4.2378-2383.1995 · Cited by 246 · cited 1×
“replication of these viruses in the infected host [4,5].”
BackgroundProteomic Analysis by Multidimensional Protein Identification Technology
Florens, L., & Washburn, M. P. (2006) · New and Emerging Proteomic Techniques · doi:10.1385/1-59745-026-x:159 · Cited by 240 · cited 1×
“The immunoprecipitates were proteolyzed without prior separation of protein bands by SDS-PAGE and peptide mixtures analyzed by multidimensional protein identification technology (MudPIT, [19]).”
MethodSelf-citationFletcher, T. M., Brichacek, B., Sharova, N., Newman, M. A., Stivahtis, G., Sharp, P. M., Emerman, M., Hahn, B. H., & Stevenson, M. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb01003.x · Cited by 237 · cited 5×
“These findings indicate that Vpx facilitates macrophage infection by acting prior to and/ or during reverse transcription, rather than by facilitating nuclear transport of the fully reverse transcribed preintegration complex, as has been thought previously ([3], reviewed in [10]).”
BackgroundInfluentialLentiviral Vpr usurps Cul4–DDB1[VprBP] E3 ubiquitin ligase to modulate cell cycle
Hrecka, K., Gierszewska, M., Srivastava, S., Kozaczkiewicz, L., Swanson, S. K., Florens, L., Washburn, M. P., & Skowronski, J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702102104 · Cited by 228 · cited 10×
“Results from recent proteomic studies revealed that lentiviral Vpr proteins associate with components of the ubiquitin proteasome system (UPS), such as Vpr Binding Protein (VprBP, GenBank NM014703) termed also DDB1 and CUL4associated factor 1 (DCAF1), damaged DNA-binding protein 1 (DDB1, GenBank U18299), DET1 and DDB1…”
BackgroundMethodInfluentialSelf-citationSchröfelbauer, B., Yu, Q., Zeitlin, S. G., & Landau, N. R. (2005) · Journal of Virology · doi:10.1128/jvi.79.17.10978-10987.2005 · Cited by 218
The control of viral infection by tripartite motif proteins and cyclophilin A
Towers, G. J. (2007) · Retrovirology · doi:10.1186/1742-4690-4-40 · Cited by 211 · cited 1×
“TRIM5a is a E3 ubiquitin ligase that inactivates the incoming virions, probably by deregulating their uncoating so rapidly that the late reverse transcripts fail to accumulate [26,27,28].”
BackgroundGoujon, C., Rivière, L., Jarrosson-Wuilleme, L., Bernaud, J., Rigal, D., Darlix, J.-L., & Cimarelli, A. (2007) · Retrovirology · doi:10.1186/1742-4690-4-2 · Cited by 205 · cited 1×
“. In more recent studies HIV-2 and SIVsm Vpx proteins were found to promote accumulation of reverse transcribed viral genomes upon infection of dendritic cells (DCs) and this effect may reflect the ability of Vpx to overcome a proteasome dependent mechanism that inhibits an as of yet unidentified early event in the vi…”
Activation of the ATR-mediated DNA Damage Response by the HIV-1 Viral Protein R
Roshal, M., Kim, B., Zhu, Y., Nghiem, P., & Planelles, V. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303948200 · Cited by 200 · cited 1×
“Both Vpx and Vpr bind VprBP through similar molecular interactions, yet the functional outcomes are different. Vpr uses VprBP-associated E3 to activate DNA damage checkpoint controlled by the Ataxia-telangiectasia and Rad3-related (ATR) kinase, while Vpx does not have this function and, instead, enables efficient reve…”
BackgroundHIV-1 Vpr function is mediated by interaction with the damage-specific DNA-binding protein DDB1
Schröfelbauer, B., Hakata, Y., & Landau, N. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610167104 · Cited by 187 · cited 1×
“Results from recent proteomic studies revealed that lentiviral Vpr proteins associate with components of the ubiquitin proteasome system (UPS), such as Vpr Binding Protein (VprBP, GenBank NM014703) termed also DDB1 and CUL4associated factor 1 (DCAF1), damaged DNA-binding protein 1 (DDB1, GenBank U18299), DET1 and DDB1…”
BackgroundThe Vpr protein from HIV-1: distinct roles along the viral life cycle
Le Rouzic, E., & Benichou, S. (2005) · Retrovirology · doi:10.1186/1742-4690-2-11 · Cited by 187 · cited 2×
“These findings indicate that Vpx facilitates macrophage infection by acting prior to and/ or during reverse transcription, rather than by facilitating nuclear transport of the fully reverse transcribed preintegration complex, as has been thought previously ([3], reviewed in [10]).”
BackgroundHirsch, V. M., Sharkey, M. E., Brown, C. R., Brichacek, B., Goldstein, S., Wakefield, J., Byrum, R., Elkins, W. R., Hahn, B. H., Lifson, J. D., et al. (1998) · Nature Medicine · doi:10.1038/3992 · Cited by 173 · cited 1×
“replication of these viruses in the infected host [4,5].”
BackgroundHIV-1 Vpr activates the G2 checkpoint through manipulation of the ubiquitin proteasome system
DeHart, J. L., Zimmerman, E. S., Ardon, O., Monteiro-Filho, C. M., Argañaraz, E. R., & Planelles, V. (2007) · Virology Journal · doi:10.1186/1743-422x-4-57 · Cited by 152 · cited 1×
“Evidence has been obtained showing that these interactions provide Vpr with the ability to modulate specifically the intrinsic catalytic activity of the Cullin 4 E3 containing VprBP and with a potential to influence the recruitment of substrate proteins for ubiquitination by Cullin 4, which in turn leads to the activa…”
BackgroundWen, X., Duus, K. M., Friedrich, T. D., & de Noronha, C. M. C. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703955200 · Cited by 150
Isolation and Characterization of a Novel Protein (X-ORF Product) from SIV and HIV-2
Henderson, L. E., Sowder, R. C., II, Copeland, T. D., Benveniste, R. E., & Oroszlan, S. I. (1988) · Science · doi:10.1126/science.3388031 · Cited by 149 · cited 4×
“The following antibodies were also used: anti-DDB1 (37-6200) from Zymed (Invitrogen, Carlsbad, CA, United States), anti-a-adaptin (AC1-M11) from Alexis Corp (San Diego, CA, United States), anti-Gag SIVmac 251 (13-112-100) from Advanced Biotechnologies Inc. (Columbia, MD, United States) and anti-Vpx 6D2.”
BackgroundInfluentialBiochemical mechanism of HIV-I Vpr function. Specific interaction with a cellular protein.
Zhao, L. J., Mukherjee, S., & Narayan, O. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40719-8 · Cited by 129 · cited 1×
“Significantly, DDB1, an obligatory subunit of all known Cullin 4 based E3 ubiquitin ligases [16], VprBP, a known Vpr-binding cellular protein that has been recently shown to bind DDB1 and postulated to function as a substrate receptor for Cullin 4 E3 ubiquitin ligase [15,20] and DDA1, a DDB1binding protein that links…”
BackgroundHIV-1 Nef Binds the DOCK2–ELMO1 Complex to Activate Rac and Inhibit Lymphocyte Chemotaxis
Janardhan, A., Swigut, T., Hill, B., Myers, M. P., & Skowronski, J. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020006 · Cited by 123 · cited 1×
“Detergent extracts and anti-FLAG immune complexes were analyzed by immunobltting as described previously [36].”
MethodYu, X. F., Yu, Q. C., Essex, M., & Lee, T. H. (1991) · Journal of Virology · doi:10.1128/jvi.65.9.5088-5091.1991 · Cited by 120 · cited 2×
“has no overt effect in primary T lymphocytes, as well as T and monocytic cell lines [1,2,3].”
BackgroundSelig, L., Benichou, S., Rogel, M. E., Wu, L. I., Vodicka, M. A., Sire, J., Benarous, R., & Emerman, M. (1997) · Journal of Virology · doi:10.1128/jvi.71.6.4842-4846.1997 · Cited by 118 · cited 1×
“These different outcomes likely reflect that Vpr and Vpx recruit different sets of substrates for ubiquitination by the same E3 enzyme [34,35], and that they affect differently the activities of their associated Cullin 4 E3s (see Figure S1).”
BackgroundGuyader, M., Emerman, M., Montagnier, L., & Peden, K. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb03488.x · Cited by 118
Gene acquisition in HIV and SIV
Sharp, P. M., Bailes, E., Stevenson, M., Emerman, M., & Hahn, B. H. (1996) · Nature · doi:10.1038/383586a0 · Cited by 105 · cited 1×
“Vpx is a paralogue of Vpr accessory factor encoded by all known lineages of primate lentiviruses [9].”
BackgroundConstruction and In Vitro Properties of SIV mac Mutants with Deletions in "Nonessential" Genes
GIBBS, J. S., REGIER, D. A., & DESROSIERS, R. C. (1994) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1994.10.607 · Cited by 104
Müller, B., Tessmer, U., Schubert, U., & Kräusslich, H.-G. (2000) · Journal of Virology · doi:10.1128/jvi.74.20.9727-9731.2000 · Cited by 103 · cited 1×
“Furthermore, the incoming virions probably contain at most only several hundred Vpx molecules, similar to Vpr, which also is virion recruited through its interaction with Gag p6 [6,30,31].”
BackgroundViral Modulators of Cullin RING Ubiquitin Ligases: Culling the Host Defense
Barry, M., & Früh, K. (2006) · Science's STKE · doi:10.1126/stke.3352006pe21 · Cited by 102 · cited 1×
“Indeed, viral accessory proteins are known to utilize E3 ubiquitin ligases to direct ubiquitination and proteasomal degradation of cellular proteins that mediate innate immunity to viral infection [32].”
BackgroundWu, X., Conway, J. A., Kim, J., & Kappes, J. C. (1994) · Journal of Virology · doi:10.1128/jvi.68.10.6161-6169.1994 · Cited by 75 · cited 4×
“The following antibodies were also used: anti-DDB1 (37-6200) from Zymed (Invitrogen, Carlsbad, CA, United States), anti-a-adaptin (AC1-M11) from Alexis Corp (San Diego, CA, United States), anti-Gag SIVmac 251 (13-112-100) from Advanced Biotechnologies Inc. (Columbia, MD, United States) and anti-Vpx 6D2.”
InfluentialHrecka, K., Swigut, T., Schindler, M., Kirchhoff, F., & Skowroński, J. (2005) · Journal of Virology · doi:10.1128/jvi.79.16.10650-10659.2005 · Cited by 73 · cited 2×
“Vpx and Vpr mutations were introduced into a single cycle SIVmac 239(GFP) reporter proviral clone containing a frameshift mutation in the env gene constructed by filling in a unique ClaI site [39].”
MethodPick, E., Lau, O.-S., Tsuge, T., Menon, S., Tong, Y., Dohmae, N., Plafker, S. M., Deng, X. W., & Wei, N. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.02432-06 · Cited by 59 · cited 1×
“and DDA1, a DDB1-binding protein that links to a negative regulator of Cullin4 E3 ubiquitin ligases”
BackgroundHuman Immunodeficiency Virus Type 1 Vpr Links Proteasomal Degradation and Checkpoint Activation
DeHart, J. L., & Planelles, V. (2008) · Journal of Virology · doi:10.1128/jvi.01628-07 · Cited by 49
Vif Counteracts a Cyclophilin A-Imposed Inhibition of Simian Immunodeficiency Viruses in Human Cells
Takeuchi, H., Buckler-White, A. J., Goila-Gaur, R., Miyagi, E., Khan, M. A., Opi, S., Kao, S., Sokolskaja, E., Pertel, T., Luban, J., et al. (2007) · Journal of Virology · doi:10.1128/jvi.02727-06 · Cited by 17 · cited 1×
“Whereas these observations raise the possibility that Vpx could act by counteracting TRIM5a, we note that this is not likely, because TRIM5a is expressed in Jurkat T cells [29], which we found not to restrict Vpx-deficient SIVmac virions.”
Background
Cited by
SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx
Laguette, N., Sobhian, B., Casartelli, N., Ringeard, M., Chable-Bessia, C., Ségéral, E., Yatim, A., Emiliani, S., Schwartz, O., & Benkirane, M. (2011) · Nature · doi:10.1038/nature10117 · Cited by 1,511
Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein
Hrecka, K., Hao, C., Gierszewska, M., Swanson, S. K., Kesik-Brodacka, M., Srivastava, S., Florens, L., Washburn, M. P., & Skowronski, J. (2011) · Nature · doi:10.1038/nature10195 · Cited by 1,200
Self-citationHIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase
Goldstone, D. C., Ennis-Adeniran, V., Hedden, J. J., Groom, H. C. T., Rice, G. I., Christodoulou, E., Walker, P. A., Kelly, G., Haire, L. F., Yap, M. W., et al. (2011) · Nature · doi:10.1038/nature10623 · Cited by 831
SAMHD1 restricts HIV-1 infection in resting CD4+ T cells
Baldauf, H.-M., Pan, X., Erikson, E., Schmidt, S., Daddacha, W., Burggraf, M., Schenkova, K., Ambiel, I., Wabnitz, G., Gramberg, T., et al. (2012) · Nature Medicine · doi:10.1038/nm.2964 · Cited by 597
HIV-1 Accessory Proteins—Ensuring Viral Survival in a Hostile Environment
Malim, M. H., & Emerman, M. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.04.008 · Cited by 551
“Rather than increasing the activity of the cullin4A-DDB1DCAF1 complex toward normal substrates, an alternative model is that Vpr recruits a novel substrate (whose expression is necessary for cell-cycle progression) for ubiquitylation (and degradation).”
BackgroundInfluential
Metadata
- Authors
- Srivastava, S., Swanson, S. K., Manel, N., Florens, L., Washburn, M. P., & Skowronski, J.
- Affiliations
- Cold Spring Harbor Laboratory (US)
- Stowers Institute for Medical Research (US)
- New York University (US)
- Venue
- PLoS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2008-05-09
- Volume
- 4
- Issue
- 5
- Pages
- e1000059
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- PMC
- PMC2330158
- OpenAlex
- W2068349374
- Cited by
- 209
- References
- 40
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 3 · 2023: 2 · 2022: 2 · 2021: 7 · 2020: 7 · 2019: 14 · 2018: 7 · 2017: 10 · 2016: 12 · 2015: 11 · 2014: 24 · 2013: 24 · 2012: 29
- FWCI
- 5.84
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Pathogens (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (acceptedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- National Institute of Allergy and Infectious Diseases (AI-77459, AI 42561, AI033303, R37AI033303, R01AI077459, R01AI042561)
- Topics
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
- Keywords
- Vpx, VprBP, DCAF1, DDB1, HIV-2, reverse transcription, ubiquitin-proteasome system, monocyte-derived cells
- MeSH terms
- Animals, Cell Line, Fluoresceins, Humans, Leukocytes, Mononuclear, Macrophages, Simian Immunodeficiency Virus, Signal Transduction, CD4-Positive T-Lymphocytes, Gene Expression Regulation, Viral, Macrophage Colony-Stimulating Factor, Gene Products, vpr, Ubiquitin-Protein Ligases, Cullin Proteins, Adaptor Proteins, Signal Transducing, Viral Regulatory and Accessory Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.